4 completed, 2 not yet recruiting, 2 terminated, 1 active not recruiting. 5 Phase 1, 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Active not recruiting 1, Terminated 1 |
| Not applicable | 2 | Not yet recruiting 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Cutaneous Lymphoma: new trials by email Literature Review of Cutaneous Lymphoma trials Research Report on Cutaneous Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FLASH Pilot Phase 1 Safety Study IntraOp Mobetron UHDR, Linac - Cutaneous Lymphoma | Not applicable | Not yet recruiting | Lesley A. Jarvis | 10 | 2029-10-31 | 2026-05-27 |
| Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 Quality-of-Life Assessment, Questionnaire Administration - Cutaneous Lymphoma | Recruiting | City of Hope Medical Center | 1250 | 2023-08-17 | 2026-01-28 | |
| Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas Biologic Samples - Cutaneous Lymphoma | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 500 | 2020-09-30 | 2020-08-20 |
| Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine - Lymphoma, Immune System Diseases | Phase 1 | Active not recruiting | UNC Lineberger Comprehensive Cancer Center | 43 | 2018-10-29 | 2026-06-12 |
| T-VEC in Non-melanoma Skin Cancer Talimogene Laherparepvec (T-VEC) - Non-melanoma Skin Cancer, Basal Cell Carcinoma | Phase 1 | Completed | University of Zurich | 26 | 2018-04-19 | 2022-03-18 |
| Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma Istodax, Doxil - Lymphoma, T-Cell Lymphoma | Phase 1 | Completed | Weiyun Ai | 24 | 2014-03-04 | 2020-06-09 |
| Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing Cutaneous Lymphoma, Other Skin Disorders | Terminated | Stanford University | 70 | 2011-06-01 | 2016-06-24 | |
| Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level Brentuximab vedotin - Non-Hodgkin Lymphoma (NHL), Cutaneous Lymphoma | Phase 2 | Completed | Youn Kim | 36 | 2011-05-01 | 2017-04-05 |
| Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides Total skin electron beam therapy (TSEBT), Vorinostat - Cutaneous Lymphoma, Cutaneous T-cell Lymphoma | Phase 1 / Phase 2 | Terminated | Stanford University | 28 | 2010-12-01 | 2017-11-20 |
| ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells ATRA plus G-CSF (filgrastim, NEUPOGEN (R)) combination - Multiple Myeloma, Cutaneous Lymphoma | Phase 1 | Completed | Peter MacCallum Cancer Centre, Australia | 6 | 2005-03-01 | 2006-11-17 |
Lymphoma, T-Cell, Cutaneous (10) · Mycosis Fungoides (3) · Lymphoma (2) · Sezary Syndrome (2) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Squamous Cell (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphomatoid Papulosis (1) · Lymphoproliferative Disorders (1) · Multiple Myeloma (1)
Hemic and Lymphatic Diseases (10) · Neoplasms by Histologic Type (10) · Immune System Diseases (9) · Immunoproliferative Disorders (9) · Lymphatic Diseases (9) · Lymphoma, Non-Hodgkin (9) · Lymphoma, T-Cell (9) · Lymphoproliferative Disorders (9) · Neoplasms (9) · Lymphoma (8) · Adenocarcinoma (1) · Blood Protein Disorders (1) · Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Cardiovascular Diseases (1)
Bendamustine Hydrochloride (1) · Brentuximab Vedotin (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Particle Accelerators (1) · Tretinoin (1) · Vorinostat (1) · fludarabine (1) · liposomal doxorubicin (1) · romidepsin (1) · talimogene laherparepvec (1)
Stanford University (2) · Assistance Publique - Hôpitaux de Paris (1) · City of Hope Medical Center (1) · Lesley A. Jarvis (1) · Peter MacCallum Cancer Centre, Australia (1) · UNC Lineberger Comprehensive Cancer Center (1) · University of Zurich (1) · Weiyun Ai (1) · Youn Kim (1)
United States (6) · Australia (1) · Switzerland (1)
Youn H Kim (2) · Ai Wei, M.D. (1) · Christiane Querfeld (1) · Kirsten E Herbert, MBBS (1) · Lesley A Jarvis, MD (1) · Miles Prince, MBBS (1) · Natalie Grover, MD (1) · Paul Khavari, MD (1) · Reinhard Dummer, Prof. Dr. (1)
P30CA033572 (1), R01CA247497 (1)